Trademark: 98107092
Word
SUNVAX MRNA THERAPEUTICS
Status Date
Tuesday, May 21, 2024
Filing Date
Friday, July 28, 2023
Published for Opposition
Tuesday, May 21, 2024
1 Lipids used in the manufacture of cosmetics, beverages, food products and food supplements for industry and scientific use; Nucleotides for scientific and industrial research use in the nature of mRNA and lipid nanoparticle-mRNA; nanoparticles for industrial purposes and scientific use, namely, lipid nanoparticles for mRNA delivery
The mark consists of an image of the sun in orange, bordered in yellow with a partially shaded blue helical strand superimposed on blue wings followed by the words "SUNVAX MRNA THERAPEUTICS" in blue. The color white represents background or transparency only and is not part of the mark.
SUN VAX MRNA THERAPEUTICS
The color(s) blue, orange and yellow is/are claimed as a feature of the mark.
"MRNA THERAPEUTICS"
Aug 1, 2023
New Application Entered
Aug 28, 2023
New Application Office Supplied Data Entered
Aug 29, 2023
Notice Of Design Search Code E-Mailed
Mar 29, 2024
Assigned To Examiner
Apr 10, 2024
Non-Final Action Written
Apr 10, 2024
Non-Final Action E-Mailed
Apr 10, 2024
Notification Of Non-Final Action E-Mailed
Apr 15, 2024
Examiners Amendment -Written
Apr 15, 2024
Examiners Amendment E-Mailed
Apr 15, 2024
Notification Of Examiners Amendment E-Mailed
Apr 15, 2024
Examiner's Amendment Entered
Apr 15, 2024
Approved For Pub - Principal Register
May 1, 2024
Notification Of Notice Of Publication E-Mailed
May 21, 2024
Published For Opposition
May 21, 2024
Official Gazette Publication Confirmation E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
